Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer

PURPOSE: This study aimed to evaluate the efficacy and safety of pemetrexed versus gefitinib in patients with advanced non-small cell lung cancer (NSCLC) previously treated with chemotherapy. MATERIALS AND METHODS: Patients with advanced (stage IIIB or IV) or recurrent NSCLC were randomly assigned t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Young Saing, Cho, Eun Kyung, Woo, Hyun Sun, Hong, Junshik, Ahn, Hee Kyung, Park, Inkeun, Sym, Sun Jin, Kyung, Sun Young, Kang, Shin Myung, Park, Jeong-Woong, Jeong, Sung Hwan, Park, Jinny, Lee, Jae Hoon, Shin, Dong Bok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720098/
https://www.ncbi.nlm.nih.gov/pubmed/25761488
http://dx.doi.org/10.4143/crt.2014.307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720098/
https://www.ncbi.nlm.nih.gov/pubmed/25761488
http://dx.doi.org/10.4143/crt.2014.307

Ejemplares similares